Merus N.v.

Leonardo Andres Sirulnik

Alexander Berthold Hendrik Bakker

Pieter Fokko Van Loo

Ernesto Isaac Wasserman

Cornelis Jacob Johannes George Bol

The disclosure relates to means and methods of treating a subject for a CLEC12A positive cancer. In some embodiments the method comprises treating the subject in need thereof with two or more administrations of a bispecific antibody that binds CD3 and CLEC12A, wherein in a first administration an first amount of the bispecific antibody is administered and wherein in each of the subsequent administrations the amount of bispecific antibody is higher than the amount of bispecific antibody in the first administration. In some embodiments CLEC12A positive cancer treatment methods are provided at intervals and dosing regimens that spare hemopoietic stem cell compartment allowing for recovery of normal CLEC12A positive hemopoietic cells.

Growing community of inventors

Utrecht, Netherlands

Leonardo Andres Sirulnik